Advantages of Our Biomanufacturing Approach
• Seamless transition from clinical to commercial scale
• Eliminates risk to process and product as you scale
• More exible and ecient process validation
• Utilizes benets of disposable technologies
Expanding to 270,000 L
across 4 countries by 2022
Leading the Industry in
Scale-Out Biomanufacturing
The world's leading global single-source
platform from concept to commercialization
